Prostate Cancer Clinical Trial
High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB)
Summary
The purpose of this study is to find out the effects (good and bad) of using newer technologies that allow very precise delivery of radiation. These newer technologies are Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT).
Full Description
In this study the treating physicians will deliver a high dose of radiation to pelvic lymph nodes of 56 Gy (Gy/Gray = measure of amount of radiation) and at the same time give a boost (additional) radiation to the prostate itself (to 70 Gy). The study will evaluate the response of the cancer and side effects of radiation to pelvic lymph nodes and to the prostate.
It is hoped that these newer technologies will:
allow a higher daily dose of radiation to the tumor and pelvic nodes
avoid nearby normal tissue and organs like the rectum and bladder
prevent the cancer from spreading or coming back
Eligibility Criteria
Inclusion Criteria:
Histologically confirmed, adenocarcinoma of the prostate
T1-2N0M0 with risk of pelvic lymph nodes involvement >25% by Roach formula [(2/3xPSA) + (Gleason Score - 6)x10], or any T3-4N0M0
Karnofsky Performance Scale > 70.
Prostate tumor biopsy grading by Gleason score classification is mandatory prior to registration.
No prior pelvic or prostate radiation or chemotherapy for any reason; induction hormonal therapy prior to registration is acceptable.
Patients must sign a study-specific consent form prior to registration.
No evidence of distant metastases (Bone scanning)
Exclusion Criteria:
Clinical or pathological evidence of distant metastases (M1).
Radical surgery for carcinoma of the prostate
History of prior chemotherapy
History of prior pelvic radiation therapy
Children (age < 18).
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Milwaukee Wisconsin, 53226, United States
How clear is this clinincal trial information?